CA
SLS icon

CoreCap Advisors’s SELLAS Life Sciences SLS Stock Holding History

CoreCap Advisors’s Portfolio SLS Stock Details SLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$8.49K Hold
690
– – ﹤0.01% 2113
2026
Q2 		$10.2K Buy
+690
New +$4.76K ﹤0.01% 2058

Other funds holding SLS

EFG
Everhart Financial Group Dublin, Ohio $1.62B AUM 25.73% 1-Year Est. Return
EM
ELCO Management New York $213M AUM 25.23% 1-Year Est. Return
IFG
Independent Financial Group San Diego, California $5.51B AUM 33.52% 1-Year Est. Return
RI
Ridgewood Investments Springfield, New Jersey $271M AUM
FD
Financial Designs Claremont, California $194M AUM 10.52% 1-Year Est. Return
FFBTD
First Financial Bank - Trust Division Hamilton, Ohio $1.39B AUM 15.59% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
AAG
Armstrong Advisory Group Needham, Massachusetts $1.66B AUM 13.15% 1-Year Est. Return
FFO
Fortitude Family Office Scottsdale, Arizona $586M AUM 20.58% 1-Year Est. Return

CoreCap Advisors's SLS Position: Q3 2026 in Review

CoreCap Advisors held its SELLAS Life Sciences (SLS) position steady in Q3 2026 at 690 shares worth $8.49K. The position accounts for ﹤0.01% of the portfolio, ranked #2113.

CoreCap Advisors first reported a position in SLS in Q2 2026 and has held it in 2 quarters since. The position peaked at $10.2K in Q2 2026. 13 funds tracked by Wall St. Rank hold SLS as of Q3 2026.

  • CoreCap Advisors held 690 shares of SELLAS Life Sciences worth $8.49K as of Q3 2026.
  • CoreCap Advisors left its SELLAS Life Sciences share count unchanged in Q3 2026.
  • SELLAS Life Sciences made up ﹤0.01% of CoreCap Advisors's portfolio in Q3 2026, its #2113 holding.
  • CoreCap Advisors first reported a position in SELLAS Life Sciences in Q2 2026 and has held it in 2 quarters since.
  • CoreCap Advisors's SELLAS Life Sciences position peaked at $10.2K in Q2 2026.
  • 13 funds tracked by Wall St. Rank held SELLAS Life Sciences as of Q3 2026.

Based on CoreCap Advisors's 13F filing for Q3 2026, filed 8 Oct 2026.